CXCL8 and breast carcinoma: Moreover, toxicity against breast cancer cells strongly correlated with cytokine inhibition with p = 0.023 for IL-1β and p < 0.001 for TNF-α, IL-6, IL-8, and IL-10 (Figure S1).